Results 141 to 150 of about 685,817 (173)

Comparison of whole-cell versus acellular pertussis vaccine effectiveness in school clusters of pertussis, France, 2013

Médecine Et Maladies Infectieuses, 2020
OBJECTIVES AND METHOD We conducted a prospective study in 2013 to compare the whole-cell versus acellular pertussis vaccines effectiveness and duration of protection, following the occurrence of pertussis clusters. RESULTS During seven school outbreaks,
N Guiso, C Six, D Levy-Bruhl
exaly   +2 more sources

Immunogenicity and safety of BPZE1, an intranasal live attenuated pertussis vaccine, versus tetanus-diphtheria-acellular pertussis vaccine: a randomised, double-blind, phase 2b trial.

The Lancet, 2023
BACKGROUND Bordetella pertussis epidemics persist as transmission remains unabated despite high acellular pertussis vaccination rates. BPZE1, a live attenuated intranasal pertussis vaccine, was designed to prevent B pertussis infection and disease.
C. Keech, Vicki E. Miller, Barbara Rizzardi, Christopher Hoyle, M. Pryor, J. Ferrand, K. Solovay, M. Thalen, S. Noviello, Peter Goldstein, A. Gorringe, Breeze E. Cavell, Qiu-Shui He, A. Barkoff, Keith Rubin, C. Locht   +15 more
semanticscholar   +1 more source

Phase II trial of whole-cell pertussis vaccine vs an acellular vaccine containing agglutinogens

Lancet, The, 1991
L A Ashworth, L A E Ashworth, L I Irons   +2 more
exaly   +2 more sources

Economic evaluation of pertussis prevention by whole-cell and acellular vaccine in Germany

European Journal of Pediatrics, 1998
Eddy van Doorslaer, H J Schmitt
exaly   +2 more sources

A Randomized Controlled Trial of the Safety and Immunogenicity of Tetanus, Diphtheria, and Acellular Pertussis Vaccine Immunization During Pregnancy and Subsequent Infant Immune Response

Clinical Infectious Diseases, 2018
Background Immunization of pregnant women with tetanus-diphtheria-acellular pertussis vaccine (Tdap) provides protection against pertussis to the newborn infant.
Scott A. Halperin, J. M. Langley, L. Ye, D. MacKinnon-Cameron, M. ElSherif, Victoria M. Allen, Bruce F. Smith, B. Halperin, Shelly A. McNeil, O. Vanderkooi, S. Dwinnell, R. Wilson, B. Tapiéro, M. Boucher, N. Le Saux, A. Gruslin, W. Vaudry, Sue Chandra, S. Dobson, D. Money   +19 more
semanticscholar   +1 more source

Reduced risk of pertussis in whole-cell compared to acellular vaccine recipients is not confounded by age or receipt of booster-doses.

Vaccine, 2015
S. Sheridan, R. Ware, K. Grimwood, Stephen B. Lambert   +3 more
semanticscholar   +1 more source

A genetically inactivated two-component acellular pertussis vaccine, alone or combined with tetanus and reduced-dose diphtheria vaccines, in adolescents: a phase 2/3, randomised controlled non-inferiority trial.

Lancet. Infectious Diseases (Print), 2018
S. Sricharoenchai, C. Sirivichayakul, K. Chokephaibulkit, P. Pitisuttithum, Jittima Dhitavat, Arom Pitisuthitham, W. Phongsamart, K. Boonnak, K. Lapphra, Yupa Sabmee, O. Wittawatmongkol, Pailinrut Chinwangso, I. Poredi, J. Pêtre, Thai Hong Pham, S. Viviani   +15 more
semanticscholar   +1 more source

Cost-effectiveness analysis of universal maternal immunization with tetanus-diphtheria-acellular pertussis (Tdap) vaccine in Brazil.

Vaccine, 2016
A. M. Sartori, P. D. de Soárez, E. Fernandes, Ligia Castellon Figueiredo Gryninger, J. Y. K. Viscondi, H. M. Novaes   +5 more
semanticscholar   +1 more source

Economic Evaluation of a New Acellular Vaccine for Pertussis in Canada

PharmacoEconomics (Auckland), 2012
M. Iskedjian, T. Einarson, B. O'Brien, J. De Serres, R. Gold, I. Gemmill, N. Milkovich, A. Rosner   +7 more
semanticscholar   +1 more source

Safety of reduced-antigen-content tetanus–diphtheria–acellular pertussis vaccine in adolescents as a sixth consecutive dose of acellular pertussis–containing vaccine

Journal of Pediatrics, 2006
Leonard Friedland, Barbara Howe
exaly